230 related articles for article (PubMed ID: 25673873)
1. The peripheral blood of Aβ binding RBC as a biomarker for diagnosis of Alzheimer's disease.
Lan J; Liu J; Zhao Z; Xue R; Zhang N; Zhang P; Zhao P; Zheng F; Sun X
Age Ageing; 2015 May; 44(3):458-64. PubMed ID: 25673873
[TBL] [Abstract][Full Text] [Related]
2. Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer's disease?
Mohanty JG; Eckley DM; Williamson JD; Launer LJ; Rifkind JM
Adv Exp Med Biol; 2008; 614():29-35. PubMed ID: 18290311
[TBL] [Abstract][Full Text] [Related]
3. Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer's Disease.
Baldacci F; Daniele S; Piccarducci R; Giampietri L; Pietrobono D; Giorgi FS; Nicoletti V; Frosini D; Libertini P; Lo Gerfo A; Petrozzi L; Donadio E; Betti L; Trincavelli ML; Siciliano G; Ceravolo R; Tognoni G; Bonuccelli U; Martini C
Mol Neurobiol; 2019 Sep; 56(9):6451-6459. PubMed ID: 30826968
[TBL] [Abstract][Full Text] [Related]
4. Amyloid β levels in human red blood cells.
Kiko T; Nakagawa K; Satoh A; Tsuduki T; Furukawa K; Arai H; Miyazawa T
PLoS One; 2012; 7(11):e49620. PubMed ID: 23166730
[TBL] [Abstract][Full Text] [Related]
5. High Levels of
Piccarducci R; Pietrobono D; Pellegrini C; Daniele S; Fornai M; Antonioli L; Trincavelli ML; Blandizzi C; Martini C
Oxid Med Cell Longev; 2019; 2019():5030475. PubMed ID: 31281579
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein C-III is an amyloid-β-binding protein and an early marker for Alzheimer's disease.
Shih YH; Tsai KJ; Lee CW; Shiesh SC; Chen WT; Pai MC; Kuo YM
J Alzheimers Dis; 2014; 41(3):855-65. PubMed ID: 24685634
[TBL] [Abstract][Full Text] [Related]
7. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
8. The binding of Aβ1-42 to lipid rafts of RBC is enhanced by dietary docosahexaenoic acid in rats: Implicates to Alzheimer's disease.
Hashimoto M; Hossain S; Katakura M; Al Mamun A; Shido O
Biochim Biophys Acta; 2015 Jun; 1848(6):1402-9. PubMed ID: 25782726
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the Levels of Amyloid-β, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer's Disease: Possible Interactions between Amyloid-β and These Lipids.
Yamashita S; Kiko T; Fujiwara H; Hashimoto M; Nakagawa K; Kinoshita M; Furukawa K; Arai H; Miyazawa T
J Alzheimers Dis; 2016; 50(2):527-37. PubMed ID: 26682681
[TBL] [Abstract][Full Text] [Related]
10. Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease.
Watt AD; Perez KA; Faux NG; Pike KE; Rowe CC; Bourgeat P; Salvado O; Masters CL; Villemagne VL; Barnham KJ
J Alzheimers Dis; 2011; 24(1):47-59. PubMed ID: 21157020
[TBL] [Abstract][Full Text] [Related]
11. Influence of beta-amyloid fibrils on the interactions between red blood cells and endothelial cells.
Ravi LB; Mohanty JG; Chrest FJ; Jayakumar R; Nagababu E; Usatyuk PV; Natarajan V; Rifkind JM
Neurol Res; 2004 Jul; 26(5):579-85. PubMed ID: 15265278
[TBL] [Abstract][Full Text] [Related]
12. Oral glucose loading modulates plasma β-amyloid level in alzheimer's disease patients: potential diagnostic method for Alzheimer's disease.
Takeda S; Sato N; Uchio-Yamada K; Yu H; Moriguchi A; Rakugi H; Morishita R
Dement Geriatr Cogn Disord; 2012; 34(1):25-30. PubMed ID: 22889768
[TBL] [Abstract][Full Text] [Related]
13. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
14. Amyloid Metabolism and Amyloid-Targeting Blood-Based Biomarkers of Alzheimer's Disease.
Pyun JM; Kang MJ; Ryoo N; Suh J; Youn YC; Park YH; Kim S
J Alzheimers Dis; 2020; 75(3):685-696. PubMed ID: 32390633
[TBL] [Abstract][Full Text] [Related]
15. Plasma beta-amyloid as potential biomarker of Alzheimer disease: possibility of diagnostic tool for Alzheimer disease.
Takeda S; Sato N; Rakugi H; Morishita R
Mol Biosyst; 2010 Oct; 6(10):1760-6. PubMed ID: 20567751
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-β as a Blood Biomarker for Alzheimer's Disease: A Review of Recent Literature.
Wang X; Sun Y; Li T; Cai Y; Han Y
J Alzheimers Dis; 2020; 73(3):819-832. PubMed ID: 31868667
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of albumin-amyloid beta complexes are decreased in Alzheimer's disease.
Yamamoto K; Shimada H; Koh H; Ataka S; Miki T
Geriatr Gerontol Int; 2014 Jul; 14(3):716-23. PubMed ID: 24020590
[TBL] [Abstract][Full Text] [Related]
18. Potential therapeutic implications of gelsolin in Alzheimer's disease.
Ji L; Zhao X; Hua Z
J Alzheimers Dis; 2015; 44(1):13-25. PubMed ID: 25208622
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.
Wang T; Xiao S; Liu Y; Lin Z; Su N; Li X; Li G; Zhang M; Fang Y
Int J Geriatr Psychiatry; 2014 Jul; 29(7):713-9. PubMed ID: 24318929
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
